Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine

Vaccine

Volumn 28, Issue 31, 2010, Pages 4928-4936

  Salam, Mohammad Abdus ^c   Katz, Jannet ^a,b   Michalek, Suzanne M ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF DETROIT MERCY   (United States)

Author keywords

Salmonella; Streptococcus mutans; TLRs

Indexed keywords

BACTERIAL VECTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; MYELOID DIFFERENTIATION FACTOR 88; SALMONELLOSIS VACCINE; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS MUTANS ANTIGEN SALIVA BINDING REGION; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE; MYD88 PROTEIN, MOUSE; RECOMBINANT VACCINE; STREPTOCOCCUS VACCINE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; STREPTOCOCCUS MUTANS; TH1 CELL; TH2 CELL; ANIMAL; ANTIBODY PRODUCTION; BLOOD; C57BL MOUSE; CD4+ T LYMPHOCYTE; IMMUNIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; SALIVA; SALMONELLA;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; SALIVA; SALMONELLA; SIGNAL TRANSDUCTION; STREPTOCOCCAL VACCINES; STREPTOCOCCUS MUTANS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 77954760262     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.039     Document Type: Article

References (44)

1. Loesche W.J. Role of Streptococcus mutans in human dental decay. Micobiol Rev 1986, 50:353-380.
2. Hajishengallis G., Michalek S.M. Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol 1999, 14:1-20.
3. Russell M.W., Lehner T. Characterization of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol 1978, 23:7-15.
4. Crowley P.J., Brady L.J., Piacentini D.A., Bleiweis A.S. Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect Immun 1993, 61:1547-1552.
5. Hajishengallis G., Koga T., Russell M.W. Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res 1994, 73:1493-1502.
6. Moisset A., Schatz N., Lepoivre Y., Amadio S., Wachsmann D., Scholler M., et al. Conservation of salivary glycoprotein-interacting and human immunoglobulin G-cross-reactive domains of antigen I/II in oral streptococci. Infect Immun 1994, 62:184-193.
7. Hajishengallis G., Nikolova E.B., Russell M.W. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyappatite by human secretory immunoglobulin A antibodies to the cell surface protein antigen I/II: reversal by IgA1 protease cleavage. Infect Immun 1992, 60:5057-5064.
8. Yu H., Nakano Y., Yamashita Y., Oho T., Koga T. Effects of antibodies against cell surface protein antigen PAc-glucosyltransferase fusion proteins on glucan synthesis and cell adhesion of Streptococcus mutans. Infect Immun 1997, 65:2292-2298.
9. Michalek S.M., Childers N.K. Development and outlook for a caries vaccine. Crit Rev Oral Biol 1990, 1:37-54.
10. Strugnell R., Dougan G., Chatfield S., Charles I., Fairweather N., Tite J., et al. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect Immun 1992, 60:3994-4002.
11. Huang Y., Hajishengallis G., Michalek S.M. Construction and characterization of a Salmonella enterica serovar Typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect Immun 2000, 68:1549-1556.
12. Harokopakis E., Hajishengallis G., Greenway T.E., Russell M.W., Michalek S.M. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect Immun 1997, 65:1445-1454.
13. Huang Y., Hajishengallis G., Michalek S.M. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar Typhimurium expressing an S. mutans adhesin under control of in vivo-inducible nirB promoter. Infect Immun 2001, 69:2154-2161.
14. Hajishengallis G., Russell M.W., Michalek S.M. Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun 1998, 66:1740-1743.
15. Salam M.A., Katz J., Zhang P., Hajishengallis G., Michalek S.M. Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system. Vaccine 2006, 24:5003-5015.
16. Medzhitov R., Preston-Hurlburt P., Janeway C.A.J. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
17. Beutler B., Hoebe K., Du X., Ulevitch R.J. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003, 74.
18. Muzio M., Bosisio D., Polentarutti N., D'amico G., Stoppacciaro A., Mancinelli R., et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000, 164:5998-6004.
19. + T cells and Toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect Immun 2005, 73:1350-2136.
20. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000, 165:5392-5396.
21. Weiss D.S., Raupach B., Takeda K., Akira S., Zychlinsky A. Toll-like receptors are temporally involved in host defense. J Immunol 2004, 172:4463-4469.
22. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
23. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001, 274:37692-37699.
24. Katz J., Zhang P., Martin M., Vogel S.N., Michalek S.M. Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect Immun 2006, 74:2809-2816.
25. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-950.
26. Wu H.Y., Russell M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 1993, 61:314-322.
27. Hajishengallis G., Hollingshead S.K., Koga T., Russell M.W. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 1995, 154:4322-4332.
28. Martin M., Sharpe A.H., Clements J.D., Michalek S.M. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli. J Immunol 2002, 169:1744-1752.
29. Miggin S.M., O'Neill L.A. New insights into the regulation of TLR signaling. J Leukoc Biol 2006, 80:220-226.
30. Ko H.J., Yang J.Y., Shim D.H., Yang H., Park S.M., Curtiss R., et al. Innate immunity mediated by MyD88 signal is not essential for the induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection. J Immunol 2009, 182:2305-2312.
31. Park S.M., Ko H.J., Shim D.H., Yang J.Y., Park Y.H., Curtiss R., et al. MyD88 signaling is not essential for the induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen. J Immunol 2008, 181:6447-6455.
32. Khan A.Q., Chen Q., Wu Z.Q., Paton J.C., Snapper C.M. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2. Infect Immun 2005, 73:298-307.
33. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
34. O'Brien G.C., Wang J.H., Redmond H.P. Bacterial lipoprotein induces resistance to Gram-negative sepsis in TLR4-deficient mice via enhanced bacterial clearance. J Immunol 2005, 174:1020-1026.
35. Qureshi S.T., Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun 2003, 4:87-94.
36. McLay J., Leonard E., Petersen S., Shapiro D., Greenspan N.S., Schreiber J.R. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. J Immunol 2002, 168:3437-3443.
37. Shao B.S., Silver P.B., Grajewski R.S., Agarwal R.K., Tang J., Chan C.-C., et al. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol 2005, 175:6303-6310.
38. Haeberle H.A., Takizawa R., Casola A., Brasier A.R., Dieterich H.J., Van Rooijen N., et al. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and Toll-like receptor 4-dependent pathways. J Infect Dis 2002, 186:1199-1206.
39. Balachandran P., Pugh N.D., Ma G., Pasco D.S. Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int Immunopharmacol 2006, 6:1808-1814.
40. Kaneko M., Akiyama Y., Takimoto H., Kumazawa Y. Mechanism of up-regulation of immunoglobulin A production in the intestine of mice unresponsive to lipopolysaccharide. Immunology 2005, 116:64-70.
41. Shim D.-H., Chang S.Y., Park S.M., Jang H., Carbis R., Czerkinsky C., et al. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a. Vaccine 2007, 25:4828-4836.
42. Hisbergues M., Magi M., Rigaux P., Steuve J., Garcia L., Goudercourt D., et al. In vivo and in vitro immunomodulation of Der p1 allergen-specific response by Lactobacillus plantarum bacteria. Clin Exp Allergy 2007, 37:1286-1295.
43. Pasare C., Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004, 21:733-741.
44. Pasare C., Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005, 17:364-368.